Pharmaceutique [1]
Over the past decade, Novartis Pharmaceuticals Canada has introduced 20 new medicines that have had an important impact on patients suffering from a wide variety of major illnesses including cancer, cardiovascular diseases, Alzheimer's disease, age-related macular degeneration, organ transplantation and osteoporosis.
A [2]
Aclasta* (zoledronic acid injection)
Bone Metabolism Regulator
Important information for healthcare professionals (2010) [5]
Public Communication (2010) [6]
Important information for healthcare professionals (2005) [7]
Public Communication (2005) [8]
*Aclasta is a registered trademark
Afinitor* / Afinitor* DISPERZ** (everolimus tablets)
mTOR Kinase Inhibitor
Patient Medication Information [10]
*Afinitor is a registered trademark **DISPERZ is a trademark
Aimovig* (erenumab)
Anti-Calcitonin gene-related peptide receptor (anti-CGRPR)
Patient Medication Information [11]
Product Monograph [12]
*AIMOVIG is a trademark of Amgen Inc. used under license by Novartis Pharmaceuticals Canada Inc.
Alomide* (Lodoxamide)
Anti-allergy Agent
Consumer Information [13]
Product Monograph [14]
*Alomide is a trademark of Novartis
Atectura* (Indacaterol (as acetate)/mometasone furoate inhalation powder hard capsules)
Bronchodilator and Inhaled Corticosteroid
Patient Medication Information [15]
Product Monograph [16]
*ATECTURA and BREEZHALER are registered trademarks
Atriance* (Nelarabine Injection)
Antineoplastic Agent
Consumer Information [17]
Product Monograph [18]
*ATRIANCE is a registered trademark
Azarga* (brinzolamide and timolol)
Topical Carbonic Anhydrase Inhibitor and Topical Beta-Adrenergic Blocking Agent
Consumer Information [19]
Product Monograph [20]
*Azarga is a Novartis product
Azopt* (Brinzolamide Ophthalmic Suspension)
Topical Carbonic Anhydrase Inhibitor
Consumer Information [21]
Product Monograph [22]
*Azopt is a trademark of Novartis
B [23]
Beovu* (brolucizumab injection)
Ophthalmological / Antineovascularisation agent
Patient Medication Information [24]
Product Monograph [25]
Important Safety Information (2022) [26]
*BEOVU is a registered trademark
Betoptic S* (Betaxolol Hydrochloride Ophthalmic Suspension)
Antiglaucoma Agent (Ophthalmic)
Consumer Information [27]
Product Monograph [28]
*a trademark of Novartis
C [29]
Ciloxan* (ciprofloxacin hydrochloride)
Antibacterial Agent
Product Monograph [30]
Patient Medication Information (Ointment) [31]
Patient Medication Information (solution) [32]
*Ciloxan is a trademark of Novartis
CiproDex* (Ciprofloxacin /Dexamethasone Otic Suspension)
Antibacterial - Corticosteroid (Otic)
Consumer Information [33]
Product Monograph [34]
*a trademark of Novartis
Cosentyx* (secukinumab)
Biological Response Modifier
Patient Medication Information [35]
Product Monograph [36]
*COSENTYX and SensoReady are registered trademarks
D [37]
Desferal* (deferoxamine mesylate for injection)
Iron and Aluminum Chelating Agent
Consumer Information [38]
Product Monograph [39]
*Desferal is a registered trademark
Diovan* (valsartan)
Angiotensin II AT1 Receptor Blocker
Consumer Information [40]
Product Monograph [41]
*Diovan is a registered trademark
Diovan*-HCT (valsartan and hydrochlorothiazide)
Angiotensin II AT1 Receptor Blocker and Diuretic
Consumer Information [42]
Product Monograph [43]
*Diovan is a registered trademark
DuoTrav PQ* (travoprost/timolol)
Prostaglandin F2a analogue and beta-adrenergic receptor blocker
Consumer Information [44]
Product Monograph [45]
*DuoTrav is a trademark of Novartis
Durezol* (difluprednate)
Topical Corticosteroid
Consumer Information [46]
Product Monograph [47]
*Durezol is a Novartis product
E [48]
Enerzair* Breezhaler* (Indacaterol (as acetate) / glycopyrronium (as bromide) / mometasone furoate inhalation powder)
Bronchodilator and Inhaled Corticosteroid
Patient Medication Information [49]
Product Monograph [50]
*ENERZAIR and BREEZHALER are registered trademarks
Entresto* (sacubitril/valsartan)
Neutral endopeptidase inhibitor/Angiotensin II AT1 receptor blocker
Product Monograph [51]
Patient Medication Information [52]
*ENTRESTO is a trademark
Estalis* (norethindrone acetate and estradiol-17ß)
Progestin-Estrogen
Consumer Information [53]
Product Monograph [54]
*Estalis is a registered trademark
Estradot* (estradiol-17ß)
Estrogen
Consumer Information [55]
Product Monograph [56]
*Estradot is a registered trademark
Exjade* (deferasirox)
Iron Chelating Agent
Consumer Information [57]
Product Monograph [58]
Important information for healthcare professionals (2009) [59]
Public Communication (2009) [60]
Important information for healthcare professionals (2008) [61]
Public Communication (2008) [62]
Important information for healthcare professionals (2007) [63]
Public Communication (2007) [64]
*Exjade is a registered trademark
Extavia* (discontinued) (Interferon beta-1b)
Immunomodulator
Consumer Information [65]
Product Monograph [66]
*Extavia is a registered trademark
F [67]
Femara* (letrozole)
Non-steroidal aromatase inhibitor; Inhibitor of estrogen biosynthesis; Anti-tumour agent
Consumer Information [68]
Product Monograph [69]
Important information for healthcare professionals (2006) [70]
Important information for healthcare professionals (2005) [71]
Public Communication (2005) [72]
*Femara is a registered trademark
Flarex* (Fluorometholone Acetate)
Corticosteroid
Consumer Information [73]
Product Monograph [74]
*Flarex is a trademark of Novartis
Foradil* (formoterol fumarate)
Bronchodilator
Patient Medication Information [75]
Product Monograph [76]
Important information for healthcare professionals (2005) [77]
*Foradil is a registered trademark
G [78]
Gilenya* (fingolimod (as fingolimod hydrochloride))
Sphingosine 1-phosphate receptor modulator
Patient Medication Information [79]
Product Monograph [80]
Important information for healthcare professionals (2012) [81]
Public Communication (2012) [82]
Health Product Risk Communication (2019) [83]
Important Safety Information - January 2021 [84]
www.gilenya.ca [85]
*Gilenya is a registered trademark
Gleevec* (imatinib mesylate)
Protein Kinase Inhibitor
Consumer Information [86]
Product Monograph [87]
Important information for healthcare professionals (2009) [88]
Fact Sheet (2009) [89]
Important information for healthcare professionals (2006) [90]
Public Communication (2006) [91]
*Gleevec is a registered trademark
H [92]
Hycamtin* (Topotecan hydrochloride for Injection)
Antineoplastic Agent
Consumer Information [93]
Product Monograph [94]
*HYCAMTIN is a registered trademark
I [95]
IZBA* (Travoprost ophthalmic solution)
Elevated Intraocular Pressure Therapy
Patient Medication Information [96]
Product Monograph [97]
*IZBA is a trademark of Novartis
Ilaris* (canakinumab)
Immunomodulator
Patient Medication Information [98]
Product Monograph [99]
*Ilaris is a registered trademark
Ilevro* (nepafenac)
Nonsteroidal Anti-Inflammatory
Product Monograph [100]
Consumer Information [101]
*Ilevro is a Novartis product
Iopidine* (apraclonidine)
Antiglaucoma Preparations and Miotics
Patient Medication Information [102]
Product Monograph [103]
*Iopidine is a trademark of Novartis
Isopto* Carpine (pilocarpine hydrochloride)
Parasympathomimetic
Consumer Information [104]
Prescribing Information and Consumer Information [105]
*Isopto is a trademark of Novartis
J [106]
Jadenu* (Deferasirox)
Iron Chelating Agent
Consumer Information [107]
Product Monograph [108]
Important information for healthcare professionals (2016) [109]
*Jadenu is a trademark
Jakavi* (ruxolitinib)
Antineoplastic Agent
Consumer Information [110]
Product Monograph [111]
Important Safety Information (2022) [112]
*Jakavi is a registered trademark
K [113]
Kesimpta* (ofatumumab)
Selective immunomodulator
Patient Medication Information [114]
Product Monograph [115]
*KESIMPTA is a trademark
Kisqali* (ribociclib)
Protein Kinase Inhibitor
Patient Medication Information [116]
Product Monograph [117]
*Kisqali is a trademark
Kymriah* (Tisagenlecleucel)
Antineoplastic and immunomodulating agents
Patient Medication Information [118]
Product Monograph [119]
*KYMRIAH is a trademark
L [120]
Lamisil* (terbinafine hydrochloride)
Antifungal Agent
Consumer Information [121]
Product Monograph [122]
Important information for healthcare professionals (2001) [123]
*Lamisil is a registered trademark
Leqvio* (Inclisiran)
Interfering Ribonucleic Acid Proprotein convertase subtilisin kexin type 9 inhibitor
Patient Medication Information [124]
Product Monograph [125]
*LEQVIO is a trademark
Lioresal* Intrathecal (baclofen injection)
Antispastic Agent
Consumer Information [126]
Product Monograph [127]
*Lioresal is a registered trademark
Lopresor* / Lopresor SR* (discontinued) (metoprolol tartrate)
B - Adrenergic Receptor Blocking Agent
Consumer Information [128]
Product Monograph [129]
*Lopresor and Lopresor SR are registered trademarks
Lucentis* (ranibizumab injection)
Antineovascularisation agent
Consumer Information [130]
Product Monograph [131]
*Lucentis is a registered trademark
Luxturna* (voretigene neparvovec)
Recombinant adeno-associated virus 2 vector-based gene therapy ATC S01XA27
Product Monograph [132]
Patient Medication Information [133]
*LUXTURNA is a registered trademark of Spark Therapeutics Inc., used under license by Novartis Pharmaceuticals Canada Inc.
M [134]
Maxidex* (dexamethasone)
Corticosteroid
Consumer Information [135]
Prescribing Information [136]
*Maxidex is a trademark of Novartis
Maxitrol* (neomycin, polymyxin B sulfates and dexamethasone)
Anti-inflammatory/Antibiotic
Consumer Information [137]
Prescribing Information [138]
*Maxitrol is a trademark of Novartis
Mayzent* (siponimod)
Sphingosine 1-phosphate receptor modulator
Product Monograph [139]
Patient Medication Information [140]
*MAYZENT is a trademark
Mekinist* (Trametinib Tablets)
Protein Kinase Inhibitor
Patient Medication Information [141]
Product Monograph [142]
*MEKINIST is a registered trademark
Myfortic* (mycophenolic acid (as mycophenolate sodium))
Immunosuppressant
Consumer Information [143]
Product Monograph [144]
Important information for healthcare professionals (2009) [145]
Public Communication (2009) [146]
Important information for health care professionals (2016) [147]
*Myfortic is a registered trademark
N [148]
Neoral* (cyclosporine)
Immunosuppressant
Consumer Information [149]
Product Monograph [150]
Neoral* Oral Solution-Recall Notice Lot H5131-January 2013 [151]
Recall of Lot H5131-Return Process-January 2013 [152]
*Neoral is a registered trademark
Nevanac* (nepafenac)
Nonsteroidal Anti-Inflammatory
Consumer Information [153]
Product Monograph [154]
*a trademark of Novartis
P [155]
Pataday* (Olopatadine Hydrochloride)
Anti-allergy Agent
Consumer Information [157]
Product Monograph [158]
*Pataday is a registered trademark of Novartis
Patanol* (Olopatadine Hydrochloride)
Anti-allergy Agent
Consumer Information [159]
Product Monograph [160]
*Patanol is a Registered trademark of
Pazeo* (olopatadine)
Anti-allergy Agent
Patient Medication Information [161]
Product Monograph [162]
*Pazeo is a trademark of Novartis
Piqray* (Alpelisib)
Antineoplastic Agent
Patient Medication Information [163]
Product Monograph [164]
*PIQRAY is a registered trademark
R [165]
Revolade* (Eltrombopag)
Thrombopoietin Receptor Agonist
Consumer Information [166]
Product Monograph [167]
Important information for healthcare professionals (2021) [168]
Public Communication (2021) [169]
Important information for healthcare professionals (2016) [170]
*REVOLADE is a registered trademark
Ritalin* / Ritalin* SR (methylphenidate hydrochloride)
Central Nervous System Stimulant
Consumer Information [171]
Product Monograph [172]
*Ritalin is a registered trademark
Rydapt* (midostaurine)
Antineoplastic Agent
Consumer Information [173]
Product Monograph [174]
*Rydapt is a trademark
S [175]
Sandimmune* I.V. (cyclosporine)
Immunosuppressant
Patient Medication Information [176]
Product Monograph [177]
*Sandimmune is a registered trademark
Sandostatin* / Sandostatin* LAR* (octreotide acetate injection) / (octreotide as acetate for injectable suspension)
Synthetic Octapeptide Analogue of Somatostatin
Consumer Information [178]
Product Monograph [179]
*Sandostatin and LAR are registered trademarks
Scemblix* (asciminib)
Antineoplastic Agent
Patient Medication Information [180]
Product Monograph [181]
*SCEMBLIX is a trademark
Seebri* Breezhaler* (glycopyrronium bromide)
Long-acting muscarinic antagonist
Consumer Information [182]
Product Monograph [183]
*Seebri and Breezhaler are registered trademarks
Simbrinza* (brinzolamide / brimonidine tartrate)
Topical Carbonic Anhydrase Inhibitor and Topical Alpha-2 Agonist Agent
Consumer Information [184]
Product Monograph [185]
*Simbrinza is a Novartis product
Simulect* (basiliximab)
Immunosuppressant
Consumer Information [186]
Product Monograph [187]
*Simulect is a registered trademark
T [188]
Tabrecta* (capmatinib)
Protein Kinase Inhibitor
Patient Medication Information [189]
Product Monograph [190]
*TABRECTA is a registered trademark
Tafinlar* (Dabrafenib (as dabrafenib mesylate))
Protein Kinase Inhibitor
Patient Medication Information [191]
Product Monograph [192]
Important information for healthcare professionals (2015) [193]
*TAFINLAR is a registered trademark
Tasigna* (nilotinib)
Protein-tyrosine Kinase Inhibitor
Consumer Information [194]
Product Monograph [195]
Important information for healthcare professionals (2013) [196]
Public Communication (2013) [197]
Important information for healthcare professionals (2011) [198]
Fact sheet (2011) [199]
Important information for healthcare professionals (2010) [200]
Fact Sheet (2010) [201]
Important information for healthcare professionals and patients (2016) [202]
*Tasigna is a registered trademark
Tegretol* (carbamazepine)
Anticonvulsant, Antimanic, For Symptomatic Relief Of Trigeminal Neuralgia
Consumer Information [203]
Product Monograph [204]
Important information for healthcare professionals (2008) [205]
*Tegretol is a registered trademark
TobraDex* (Tobramycin and Dexamethasone)
Antibacterial and Corticosteroid
Patient Medication Information [206]
Product Monograph including Patient Medication Information [207]
*Tobradex is a trademark of Novartis
Tobrex* (Tobramycin)
Antibacterial (ophthalmic)
Product Monograph [208]
Patient Medication Information [209]
*Tobrex is a trademark of Novartis
Travatan* Z (Travoprost)
Prostaglandin F2a analogue
Patient Medication Information [210]
Product Monograph including Patient Medication Information [211]
*Travatan is a trademark of Novartis
Triesence* (triamcinolone acetonide)
Visualization Agent
Consumer Information [212]
Product Monograph [213]
*Triesence is a trademark of Novartis
Trileptal* (oxcarbazepine)
Antiepileptic
Patient Medication Information [214]
Product Monograph [215]
Important information for healthcare professionals (2005) [216]
*Trileptal is a registered trademark
Tykerb* (lapatinib tablets (as lapatinib ditosylate))
Antineoplastic Agent
Consumer Information [217]
Product Monograph [218]
Important information for healthcare professionals [219]
Public Communication (2013) [220]
*TYKERB is a registered trademark
U [221]
Ultibro* Breezhaler* (indacaterol maleate and glycopyrronium bromide)
Long-acting beta2-agonist and Long-acting muscarinic antagonist
Consumer Information [222]
Product Monograph [223]
*Ultibro and Breezhaler are registered trademarks
V [224]
Vigamox* (Moxifloxacin Ophtalmic Solution)
Antibacterial (ophtalmic)
Consumer Information [225]
Product Monograph [226]
*a trademark of Novartis
Voltaren Rapide* (diclofenac potassium)
Nonsteroidal Anti-Inflammatory Drug (NSAID)
Consumer Information [227]
Product Monograph [228]
Important information for healthcare professionals (2014) [229]
Public Communication (2014) [230]
*Voltaren Rapide is a registered trademark
Voltaren* / Voltaren* SR (diclofenac sodium)
Nonsteroidal Anti-Inflammatory Drug (NSAID)
Consumer Information [231]
Product Monograph [232]
Important information for healthcare professionals (2014) [233]
Public Communication (2014) [234]
*Voltaren is a registered trademark
Voltaren* Ophtha (Diclofenac Sodium)
Anti-inflammatory Analgesic Agent
Consumer Information [235]
Product Monograph [236]
*Voltaren is a trademark of Novartis
Votrient* (Pazopanib (as pazopanib hydrochloride))
Antineoplastic Agent
Consumer Information [237]
Product Monograph [238]
Important information for healthcare professionals (2013) [239]
Public Communication (2013) [240]
*VOTRIENT is a registered trademark
X [241]
Xiidra* (Lifitegrast)
Lymphocyte function associated antigen-1 (LFA-1) antagonist
Patient Medication Information [242]
Product Monograph [243]
*XIIDRA is a registered trademark
Xolair* (omalizumab)
IgE-Neutralizing Antibody (Anti-IgE)
Consumer Information [244]
Product Monograph [245]
*Xolair is a registered trademark
Z [246]
Zofran* / Zofran* ODT ((ondansetron hydrochloride dihydrate))
Antiemetic
Consumer Information [247]
Product Monograph [248]
Important information for healthcare professionals (2014) [249]
Important information for healthcare professionals (2012) [250]
Public Communication (2012) [251]
*ZOFRAN is a registered trademark
Zolgensma* (onasemnogene abeparvovec)
Other drugs for disorders of the musculo-skeletal system
Product Monograph [252]
Patient Medication Information [253]
Important Safety Information (2022) [254]
*ZOLGENSMA is a registered trademark
Zometa* (zoledronic acid for injection)
Bone Metabolism Regulator
Consumer Information [255]
Product Monograph [256]
Important information for healthcare professionals (2005) [257]
Public Communication (2005) [258]
Important information for healthcare professionals (2004) [259]
*Zometa is a registered trademark
Zykadia* (Ceritinib)
Protein Kinase Inhibitor
Consumer Information [260]
Product Monograph [261]
Important information for healthcare professionals (2015) [262]
*ZYKADIA is a registered trademark